Outlook Therapeutics (OTLK) Stock Chart & Stock Price History $5.56 -0.12 (-2.11%) (As of 09/27/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Outlook Therapeutics Stock Price Performance5 Day Performance-0.36%1 Month Performance-23.84%3 Month Performance-24.66%6 Month Performance-53.43%Year-To-Date Performance-29.44%1 Year Performance+25.79% Ad Behind the MarketsWARNING: “Buffett Indicator” flashing for first time in 50 yearsThe stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.Take these 4 steps today to protect your retirement NOW OTLK Stock Chart for Sunday, September, 29, 2024 OTLK Chart by TradingView Outlook Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/27/2024$5.68$5.56-2.11%$5.87$5.56103,165 shs$130.14 million09/26/2024$5.52$5.68+2.90%$5.75$5.51138,234 shs$134.39 million09/25/2024$5.58$5.52-1.08%$5.79$5.46287,870 shs$130.60 million09/24/2024$5.58$5.58$5.67$5.22371,288 shs$130.61 million09/23/2024$6.00$5.58-7.00%$6.10$5.57306,228 shs$130.61 million09/20/2024$6.00$6.00$6.15$5.871.00 million shs$140.44 millionWARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.Take these 4 steps today to protect your retirement NOW09/19/2024$5.93$6.00+1.18%$6.16$5.84265,940 shs$140.44 million09/18/2024$6.04$5.93-1.82%$6.59$5.92316,833 shs$138.80 million09/17/2024$5.93$6.04+1.85%$6.56$5.97326,264 shs$142.91 million09/16/2024$6.47$5.93-8.35%$6.67$5.88370,562 shs$138.80 million09/13/2024$6.49$6.47-0.31%$6.80$6.35380,021 shs$151.44 million09/12/2024$7.03$6.49-7.68%$7.26$6.45446,261 shs$151.91 million09/11/2024$7.79$7.03-9.76%$7.85$6.94496,661 shs$164.54 million09/10/2024$8.01$7.79-2.75%$8.24$7.66255,839 shs$182.33 million09/09/2024$7.95$8.01+0.75%$8.32$7.95185,009 shs$187.48 million09/06/2024$7.82$7.95+1.66%$8.05$7.63150,074 shs$188.10 million09/05/2024$7.36$7.82+6.32%$7.89$7.20152,436 shs$185.02 million09/04/2024$6.74$7.36+9.12%$7.49$6.80332,656 shs$174.02 million09/03/2024$7.35$6.74-8.30%$7.44$6.62343,360 shs$159.47 million09/02/2024$7.35$7.35$7.53$7.2399,000 shs$173.90 million08/30/2024$7.30$7.35+0.68%$7.53$7.2399,023 shs$172.03 million08/29/2024$7.53$7.30-3.05%$7.63$7.3077,902 shs$170.86 million08/28/2024$7.47$7.53+0.80%$7.66$7.39103,393 shs$176.25 million08/27/2024$7.68$7.47-2.73%$7.66$7.4465,206 shs$174.84 million08/26/2024$7.53$7.68+1.99%$7.83$7.50120,662 shs$179.76 million08/23/2024$7.17$7.53+5.02%$7.89$7.15179,057 shs$178.16 million08/22/2024$7.27$7.17-1.38%$7.55$7.1694,680 shs$167.82 million08/21/2024$7.10$7.27+2.39%$7.27$7.0697,665 shs$170.16 million08/20/2024$7.16$7.10-0.84%$7.39$7.05240,384 shs$166.21 million08/19/2024$7.71$7.16-7.13%$7.70$7.16241,183 shs$167.62 million08/16/2024$7.68$7.71+0.39%$8.09$7.49197,695 shs$180.49 million08/15/2024$7.34$7.68+4.63%$7.78$7.4558,724 shs$179.79 million08/14/2024$7.75$7.34-5.29%$8.03$7.24137,257 shs$171.80 million08/13/2024$7.51$7.75+3.20%$7.80$7.45123,663 shs$181.40 million08/12/2024$7.34$7.51+2.32%$7.77$7.34139,523 shs$175.78 million08/09/2024$7.42$7.34-1.08%$7.55$7.29101,906 shs$171.80 million08/08/2024$7.01$7.42+5.85%$7.42$6.94162,698 shs$173.67 million08/07/2024$7.27$7.01-3.58%$7.39$6.90255,032 shs$164.08 million08/06/2024$7.05$7.27+3.12%$7.33$6.96163,542 shs$170.16 million08/05/2024$7.33$7.05-3.82%$7.22$6.90162,367 shs$165.01 millionWARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.Take these 4 steps today to protect your retirement NOW08/02/2024$7.40$7.33-0.95%$7.44$6.98240,348 shs$171.60 million08/01/2024$7.75$7.40-4.52%$7.75$7.20172,731 shs$173.23 million07/31/2024$7.61$7.75+1.84%$7.87$7.51130,693 shs$181.43 million07/30/2024$8.00$7.61-4.88%$8.06$7.56128,076 shs$178.15 million07/29/2024$8.56$8.00-6.54%$8.52$7.93232,497 shs$187.25 million07/26/2024$8.34$8.56+2.64%$8.70$8.34303,594 shs$200.39 million07/25/2024$8.16$8.34+2.21%$8.65$8.19249,848 shs$195.24 million07/24/2024$8.52$8.16-4.23%$8.54$8.0981,470 shs$190.99 million07/23/2024$8.13$8.52+4.80%$8.68$8.11181,651 shs$199.45 million07/22/2024$7.96$8.13+2.14%$8.20$7.7998,503 shs$190.32 million07/19/2024$8.11$7.96-1.85%$8.12$7.91120,218 shs$186.34 million07/18/2024$8.95$8.11-9.39%$9.10$8.02340,357 shs$189.86 million07/17/2024$9.22$8.95-2.93%$9.25$8.83200,346 shs$209.52 million07/16/2024$8.45$9.22+9.11%$9.25$8.57262,755 shs$215.84 million07/15/2024$8.78$8.45-3.76%$8.88$8.43188,675 shs$197.81 million07/12/2024$8.38$8.78+4.77%$8.82$8.25202,238 shs$205.54 million07/11/2024$7.61$8.38+10.12%$8.44$7.76463,315 shs$196.14 million07/10/2024$7.90$7.61-3.67%$7.98$7.46238,334 shs$178.12 million07/09/2024$7.86$7.90+0.51%$8.00$7.68222,592 shs$184.94 million07/08/2024$7.32$7.86+7.38%$7.90$7.23251,838 shs$184.00 million07/05/2024$7.08$7.32+3.39%$7.38$6.93170,591 shs$171.33 million07/04/2024$7.08$7.08$7.26$6.9885,302 shs$165.74 million07/03/2024$7.09$7.08-0.14%$7.20$6.9985,092 shs$165.74 million07/02/2024$7.41$7.09-4.32%$7.46$7.0899,834 shs$165.98 million07/01/2024$7.38$7.41+0.41%$7.55$7.28106,137 shs$173.44 million06/28/2024$7.51$7.38-1.73%$7.50$6.86775,813 shs$172.77 million Related Companies: Coherus BioSciences Stock Chart Protara Therapeutics Stock Chart Brainstorm Cell Therapeutics Stock Chart ProKidney Stock Chart Entrada Therapeutics Stock Chart Altimmune Stock Chart Alector Stock Chart Oculis Stock Chart Acelyrin Stock Chart Contineum Therapeutics Stock Chart This page (NASDAQ:OTLK) was last updated on 9/29/2024 by MarketBeat.com Staff From Our PartnersWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's righ...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredUrgent 2024 Election Summit [link enclosed]With the 2024 election just weeks away, a new crisis is barrelling down on America… one that could cleave the ...Porter & Company | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Outlook Therapeutics, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Outlook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.